OEM News

Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility With Abbott’s FreeStyle Libre 3 Plus CGM Sensor 

The FreeStyle Libre 3 Plus sensor can be worn for up to 15 days and sends glucose readings to the pump every minute.

By: Michael Barbella

Managing Editor

The t:slim X2 insulin pump with Control-IQ+ technology. Photo: Business Wire.

Tandem Diabetes Care Inc.’s t:slim X2 insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now compatible with Abbott’s FreeStyle Libre 3 Plus continuous glucose monitoring (CGM) sensor in the United Kingdom, Switzerland, Sweden, Finland, and Italy. The company expects to add additional countries this year, including Belgium, the Netherlands, and Germany.

“People using AID want flexibility in the devices they use,” Tandem Diabetes Care Chief Medical Officer Jordan Pinsker, M.D., stated. “The addition of Abbott’s latest generation sensor expands CGM choice for people using our Control-IQ+ technology.”

The FreeStyle Libre 3 Plus sensor can be worn for up to 15 days and sends glucose readings to the pump every minute. This data is also available on the Tandem t:slim mobile app, giving users multiple convenient ways to view their current glucose trend.

The t:slim X2 insulin pump is powered by Control-IQ+ technology, the latest generation of the Tandem advanced hybrid closed-loop algorithm, which adjusts insulin every five minutes based on predicted glucose values. It reportedly is the only system with the unique AutoBolus feature that calculates and delivers a correction bolus to help with missed meal boluses. Control-IQ+ is easy to start, use, and personalize.

“This is an exciting next step in our strategy to connect the Tandem portfolio of insulin pumps to Abbott’s FreeStyle Libre 3 Plus sensors worldwide,” Tandem Diabetes Care Senior Vice President – International Igor Friedmann stated. “We look forward to expanding access for our t:slim X2 pump users in more countries in the coming months.”

Customers in Belgium, the Netherlands, and Germany will be notified when compatibility is available in their respective countries.

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters